| 臺大學術典藏 |
2022-03-10T02:29:46Z |
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan
|
Hsu, Yin-Chen; Yu, Chih-Hsiang; Chen, Yan-Ming; Roberts, Kathryn G; Ni, Yu-Ling; Lin, Kai-Hsin; Jou, Shiann-Tarng; Lu, Meng-Yao; Chen, Shu-Huey; Wu, Kang-Hsi; Chang, Hsiu-Hao; Lin, Dong-Tsamn; Lin, Shu-Wha; Lin, Ze-Shiang; Chiu, Wei-Tzu; Chang, Chia-Ching; Ho, Bing-Ching; Mullighan, Charles G; Yu, Sung-Liang; YUNG-LI YANG |
| 臺大學術典藏 |
2022-03-10T02:30:49Z |
Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia
|
Chang, Ya-Hsuan; Yu, Chih-Hsiang; Jou, Shiann-Tarng; Lin, Chien-Yu; Lin, Kai-Hsin; Lu, Meng-Yao; Wu, Kang-Hsi; Chang, Hsiu-Hao; Lin, Dong-Tsamn; Lin, Shu-Wha; Chen, Hsuan-Yu; YUNG-LI YANG |
| 臺大學術典藏 |
2022-03-10T02:31:33Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
|
Chiang Y.-C.; PO-HAN LIN; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
Chiang Y.-C.; PO-HAN LIN; Lu T.-P.; Kuo K.-T.; Tai Y.-J.; Hsu H.-C.; Wu C.-Y.; Lee C.-Y.; Shen H.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
|
Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
|
Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN; Tseng L.-M. |
